share_log

Satellos Bioscience Inc. Opens the Market

サテロスバイオサイエンス社が市場を開かれました。

PR Newswire ·  05/15 11:04

TORONTO, May 15, 2024 /PRNewswire/ - Frank Gleeson Co-Founder and Chief Executive Officer, Satellos Bioscience Inc. (TSX: MSCL) ("Satellos" or the "Company"), and his team joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange (TSX), to open the market and celebrate the Company's graduation to TSX.

Satellos is a publicly traded biotechnology company dedicated to developing life-improving medicines to treat degenerative muscle diseases. For more information, visit .

Satellos Bioscience Inc. Opens the Market Wednesday, May 15, 2024

CNW sponsored announcement. To learn more visit .

SOURCE Toronto Stock Exchange

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする